Ofirmev, a Cadence Pharmaceuticals product, is the first form of intravenous acetaminophen in the U.S. Cadence Pharmaceuticals is expected to launch the product in the early part of this year, according to the news report.
Read the news report about Ofirmev.
Read other coverage about FDA approvals:
– FDA Approves Mindray Medical Anesthesia System
– House Hears Arguments Over FDA’s Medical Device Approval Process
– 7 GI/Endoscopy Devices Receive FDA Approval
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
